Viral Vector Regulation
Viral Vector Regulation is a regulatory framework that governs the design, production, testing, and clinical application of viral vectors used in gene therapy to ensure their safety, efficacy, and quality.
21
Publications
1.3K
Citations
125
Authors
57
Institutions
Publications per year
2017–2026
5
21
Rainer Landgraf, Elisabeth Frank, J. Matthew Aldag et al. · European Journal of Neuroscience · 2003 · 162 citations
First AAV gene therapy poised for landmark approval
Eric Smalley · Nature Biotechnology · 2017 · 130 citations
1–5 of 21
125
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 125
57
Heidelberg University
Heidelberg, Germany
2 h-index
6 publications
170 citations

University of Bristol
Bristol, United Kingdom
2 h-index
9 publications
453 citations
University of Regensburg
Regensburg, Germany
2 h-index
3 publications
728 citations
Baylor College of Medicine
Houston, United States
2 h-index
16 publications
416 citations
Rockefeller University
New York, United States
2 h-index
2 publications
353 citations

Beth Israel Deaconess Medical Center
Boston, United States
1 h-index
2 publications
324 citations

University of Turin
Turin, Italy
1 h-index
1 publications
43 citations
Spanish Oncology Genitourinary Group
Madrid, Spain
1 h-index
2 publications
68 citations
1–8 of 57
4 publications · 170 citations
4
h-index
PNAS · 2 publications · 296 citations
2
h-index
1 publications · 130 citations
1
h-index
1 publications · 17 citations
1
h-index
1 publications · 37 citations
1
h-index
1–5